XIGDUOXR (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the XIGDUO drug offered from AstraZeneca Pharmaceuticals LP. This Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | dapagliflozin and metformin hydrochloride |
| SUBSTANCE NAME: | DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-10-29 |
| END MARKETING DATE: | 0000-00-00 |
XIGDUO XR HUMAN PRESCRIPTION DRUG Details:
| Item Description | XIGDUO XR from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 1000(mg/1; mg/1) |
| START MARKETING DATE: | 2014-10-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-6225_2157a8f0-695e-4159-9919-99d7d1c8a3cf |
| PRODUCT NDC: | 0310-6225 |
| APPLICATION NUMBER: | NDA205649 |
Other DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
